GB9208492D0 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
GB9208492D0
GB9208492D0 GB929208492A GB9208492A GB9208492D0 GB 9208492 D0 GB9208492 D0 GB 9208492D0 GB 929208492 A GB929208492 A GB 929208492A GB 9208492 A GB9208492 A GB 9208492A GB 9208492 D0 GB9208492 D0 GB 9208492D0
Authority
GB
United Kingdom
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929208492A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Glaxo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo SpA filed Critical Glaxo SpA
Priority to GB929208492A priority Critical patent/GB9208492D0/en
Publication of GB9208492D0 publication Critical patent/GB9208492D0/en
Priority to ZA932642A priority patent/ZA932642B/xx
Priority to BE9300371A priority patent/BE1006343A5/fr
Priority to LU88248A priority patent/LU88248A1/fr
Priority to JP5517997A priority patent/JPH07505407A/ja
Priority to US08/046,947 priority patent/US5373018A/en
Priority to DK043193A priority patent/DK169890B1/da
Priority to PCT/EP1993/000938 priority patent/WO1993021153A1/en
Priority to KR1019940703668A priority patent/KR100264114B1/ko
Priority to GB9307808A priority patent/GB2266091B/en
Priority to CA002094076A priority patent/CA2094076A1/en
Priority to RU94045915A priority patent/RU2129544C1/ru
Priority to SK1241-94A priority patent/SK281941B6/sk
Priority to SE9301241A priority patent/SE504336C2/sv
Priority to AT0075293A priority patent/AT403917B/de
Priority to EP93201103A priority patent/EP0568136A1/en
Priority to CN93105797A priority patent/CN1042331C/zh
Priority to MX9302195A priority patent/MX9302195A/es
Priority to FR9304452A priority patent/FR2690919B1/fr
Priority to MYPI93000690A priority patent/MY112232A/en
Priority to JP5088844A priority patent/JPH0649027A/ja
Priority to IL105412A priority patent/IL105412A/en
Priority to CA002094075A priority patent/CA2094075A1/en
Priority to GR930100154A priority patent/GR1001619B/el
Priority to IT93RM000236A priority patent/IT1265325B1/it
Priority to PL93305554A priority patent/PL176451B1/pl
Priority to AU36923/93A priority patent/AU666927B2/en
Priority to ES09300771A priority patent/ES2105924B1/es
Priority to US08/047,429 priority patent/US5374648A/en
Priority to NZ247413A priority patent/NZ247413A/en
Priority to RO94-01658A priority patent/RO113242B1/ro
Priority to CZ942543A priority patent/CZ285799B6/cs
Priority to US08/047,430 priority patent/US5374649A/en
Priority to HU9402975A priority patent/HU217964B/hu
Priority to CA002094073A priority patent/CA2094073A1/en
Priority to IS3994A priority patent/IS3994A/is
Priority to CH1133/93A priority patent/CH685630A5/fr
Priority to GEAP19932602A priority patent/GEP19991704B/en
Priority to APAP/P/1993/000524A priority patent/AP480A/en
Priority to TW082103531A priority patent/TW224457B/zh
Priority to OA60570A priority patent/OA10103A/en
Priority to FI944800A priority patent/FI106198B/fi
Priority to BG99111A priority patent/BG62136B1/bg
Priority to NO943913A priority patent/NO301879B1/no
Priority to US08/351,762 priority patent/US5510367A/en
Priority to HU95P/P00538P priority patent/HU211826A9/hu
Priority to BR1100323-5A priority patent/BR1100323A/pt
Priority to HK95797A priority patent/HK95797A/xx
Priority to CY9802038A priority patent/CY2038B1/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
GB929208492A 1992-04-16 1992-04-16 Heterocyclic compounds Pending GB9208492D0 (en)

Priority Applications (49)

Application Number Priority Date Filing Date Title
GB929208492A GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds
ZA932642A ZA932642B (en) 1992-04-16 1993-04-14 Indole derivatives
BE9300371A BE1006343A5 (fr) 1992-04-16 1993-04-15 Derives de l'indole.
LU88248A LU88248A1 (fr) 1992-04-16 1993-04-15 Derives de l'indole
JP5517997A JPH07505407A (ja) 1992-04-16 1993-04-15 インドール誘導体
US08/046,947 US5373018A (en) 1992-04-16 1993-04-15 Indole derivatives and pharmaceutical use thereof
DK043193A DK169890B1 (da) 1992-04-16 1993-04-15 3-Substitueret 2-carboxy-indolderivater, farmaceutisk præparat indeholdende forbindelserne, fremgangsmåde til fremstilling af forbindelserne samt anvendelse af forbindelserne til fremstilling af et lægemiddel
PCT/EP1993/000938 WO1993021153A1 (en) 1992-04-16 1993-04-15 Indole-2-carboxylic acid derivatives
KR1019940703668A KR100264114B1 (ko) 1992-04-16 1993-04-15 인돌-2-카르복실산유도체
GB9307808A GB2266091B (en) 1992-04-16 1993-04-15 Indole derivatives
CA002094076A CA2094076A1 (en) 1992-04-16 1993-04-15 Indole derivatives
RU94045915A RU2129544C1 (ru) 1992-04-16 1993-04-15 Производные индола, способ их получения, фармацевтическая композиция
SK1241-94A SK281941B6 (sk) 1992-04-16 1993-04-15 Deriváty kyseliny indol-2-karboxylovej, ich použitie, spôsob ich prípravy a farmaceutický prípravok s ich obsahom
SE9301241A SE504336C2 (sv) 1992-04-16 1993-04-15 Indolderivat
AT0075293A AT403917B (de) 1992-04-16 1993-04-15 Indolderivate
EP93201103A EP0568136A1 (en) 1992-04-16 1993-04-15 Indole-2-carboxylic acid derivatives
CN93105797A CN1042331C (zh) 1992-04-16 1993-04-15 4,6－二氯－3－取代的－2－羧基吲哚衍生物
MX9302195A MX9302195A (es) 1992-04-16 1993-04-15 Derivados de indol, procedimiento para su reparacion y composicion farmaceutica que los comprende.
FR9304452A FR2690919B1 (fr) 1992-04-16 1993-04-15 Dérivés de l'indole.
MYPI93000690A MY112232A (en) 1992-04-16 1993-04-15 Indole derivatives
JP5088844A JPH0649027A (ja) 1992-04-16 1993-04-15 インドール誘導体
IL105412A IL105412A (en) 1992-04-16 1993-04-15 Indole derivatives, their preparation and pharmaceutical compositions containing them
CA002094075A CA2094075A1 (en) 1992-04-16 1993-04-15 Indole derivatives
GR930100154A GR1001619B (el) 1992-04-16 1993-04-15 Παράγωγα ινδόλης.
IT93RM000236A IT1265325B1 (it) 1992-04-16 1993-04-15 Derivati di indolo; procedimenti per la loro preparazione e loro impiego in medicina.
PL93305554A PL176451B1 (pl) 1992-04-16 1993-04-15 Pochodne indolu, środek farmaceutyczny zawierający pochodne indolu i sposób wytwarzania pochodnych indolu
AU36923/93A AU666927B2 (en) 1992-04-16 1993-04-15 Indole derivatives
ES09300771A ES2105924B1 (es) 1992-04-16 1993-04-15 Derivados de indol.
US08/047,429 US5374648A (en) 1992-04-16 1993-04-15 Indole derivatives and pharmaceutical use thereof
NZ247413A NZ247413A (en) 1992-04-16 1993-04-15 Indole-2-carboxylic acid derivatives and pharmaceutical compositions
RO94-01658A RO113242B1 (ro) 1992-04-16 1993-04-15 Derivati de indol, procedee de preparare, compozitie farmaceutica si metoda de tratament
CZ942543A CZ285799B6 (cs) 1992-04-16 1993-04-15 Indolové deriváty, způsob jejich výroby, jejich použití pro výrobu farmaceutických prostředků a farmaceutické prostředky s jejich obsahem
US08/047,430 US5374649A (en) 1992-04-16 1993-04-15 Indole derivatives and pharmaceutical use thereof
HU9402975A HU217964B (hu) 1992-04-16 1993-04-15 Indol-2-karbonsav-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
CA002094073A CA2094073A1 (en) 1992-04-16 1993-04-15 Indole derivatives
IS3994A IS3994A (is) 1992-04-16 1993-04-15 Hliðstæð aðferð til framleiðslu á indole afleiðum
CH1133/93A CH685630A5 (fr) 1992-04-16 1993-04-15 Dérivés de l'indole.
GEAP19932602A GEP19991704B (en) 1992-04-16 1993-04-16 Carbon Derivatives, Method for Its Production, Compositions Based Thereon
APAP/P/1993/000524A AP480A (en) 1992-04-16 1993-04-16 3-Substituted indole 2-carboxylic acid derivatives.
TW082103531A TW224457B (https=) 1992-04-16 1993-05-06
OA60570A OA10103A (en) 1992-04-16 1994-10-10 Indole derivatives
FI944800A FI106198B (fi) 1992-04-16 1994-10-12 Menetelmä terapeuttisesti käyttökelpoisten 3-substituoitujen 2-karboksi-indolijohdannaisten valmistamiseksi
BG99111A BG62136B1 (bg) 1992-04-16 1994-10-14 Индолови производни
NO943913A NO301879B1 (no) 1992-04-16 1994-10-14 Indol-derivater
US08/351,762 US5510367A (en) 1992-04-16 1994-12-08 Indole derivatives
HU95P/P00538P HU211826A9 (en) 1992-04-16 1995-06-29 Indole derivatives and pharmaceutical use thereof
BR1100323-5A BR1100323A (pt) 1992-04-16 1997-04-22 Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
HK95797A HK95797A (en) 1992-04-16 1997-06-26 Indole derivatives
CY9802038A CY2038B1 (en) 1992-04-16 1998-04-30 Indole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208492A GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB9208492D0 true GB9208492D0 (en) 1992-06-03

Family

ID=10714220

Family Applications (2)

Application Number Title Priority Date Filing Date
GB929208492A Pending GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds
GB9307808A Expired - Fee Related GB2266091B (en) 1992-04-16 1993-04-15 Indole derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9307808A Expired - Fee Related GB2266091B (en) 1992-04-16 1993-04-15 Indole derivatives

Country Status (41)

Country Link
US (4) US5373018A (https=)
EP (1) EP0568136A1 (https=)
JP (2) JPH0649027A (https=)
KR (1) KR100264114B1 (https=)
CN (1) CN1042331C (https=)
AP (1) AP480A (https=)
AT (1) AT403917B (https=)
AU (1) AU666927B2 (https=)
BE (1) BE1006343A5 (https=)
BG (1) BG62136B1 (https=)
BR (1) BR1100323A (https=)
CA (3) CA2094073A1 (https=)
CH (1) CH685630A5 (https=)
CY (1) CY2038B1 (https=)
CZ (1) CZ285799B6 (https=)
DK (1) DK169890B1 (https=)
ES (1) ES2105924B1 (https=)
FI (1) FI106198B (https=)
FR (1) FR2690919B1 (https=)
GB (2) GB9208492D0 (https=)
GE (1) GEP19991704B (https=)
GR (1) GR1001619B (https=)
HK (1) HK95797A (https=)
HU (2) HU217964B (https=)
IL (1) IL105412A (https=)
IS (1) IS3994A (https=)
IT (1) IT1265325B1 (https=)
LU (1) LU88248A1 (https=)
MX (1) MX9302195A (https=)
MY (1) MY112232A (https=)
NO (1) NO301879B1 (https=)
NZ (1) NZ247413A (https=)
OA (1) OA10103A (https=)
PL (1) PL176451B1 (https=)
RO (1) RO113242B1 (https=)
RU (1) RU2129544C1 (https=)
SE (1) SE504336C2 (https=)
SK (1) SK281941B6 (https=)
TW (1) TW224457B (https=)
WO (1) WO1993021153A1 (https=)
ZA (1) ZA932642B (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
JP3334805B2 (ja) * 1993-05-27 2002-10-15 メレルファーマスーティカルズ インコーポレイテッド ３−（インドール−３−イル）−プロペン酸誘導体類及びその製剤組成物
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
TW280819B (https=) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
GB9504361D0 (en) * 1995-03-04 1995-04-26 Glaxo Spa Heterocyclic compounds
AU4416197A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Positive ampa receptor modulation to enhance brain neurotrophic factor expression
CA2266556C (en) * 1996-09-30 2007-11-06 Hoechst Marion Roussel, Inc. Nmda (n-methyl-d-aspartate) antagonists
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
ME00189B (me) * 1998-03-26 2011-02-10 Astellas Pharma Inc Preparati sa neprekidnim oslobađanjem
RU2277096C2 (ru) * 2000-07-31 2006-05-27 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. Средства против слабоумия, содержащие производное 2-арил-8-оксодигидропурина в качестве активного ингредиента
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
JP2005518371A (ja) * 2001-12-10 2005-06-23 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療に於けるこれらの使用
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
WO2004108733A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
RU2247563C1 (ru) * 2003-06-16 2005-03-10 Пятигорская государственная фармацевтическая академия Способ получения твердой лекарственной формы, содержащей глюкозамина гидрохлорид
US7671072B2 (en) * 2003-11-26 2010-03-02 Pfizer Inc. Aminopyrazole derivatives as GSK-3 inhibitors
AU2004312530A1 (en) * 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
RU2281755C2 (ru) * 2004-04-19 2006-08-20 Пятигорская государственная фармацевтическая академия Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для ректального применения
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
BRPI0706365A2 (pt) 2006-01-06 2011-03-22 Sepracor Inc Cicloalquilaminas como inibidores da recaptação de monoamina
NZ569608A (en) * 2006-01-06 2011-09-30 Sepracor Inc Tetralone-based monoamine reuptake inhibitors
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (en) 2006-12-20 2008-07-09 sanofi-aventis Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
US20090099248A1 (en) * 2007-01-18 2009-04-16 Sepracor Inc. Inhibitors of d-amino acid oxidase
AU2008259841B2 (en) 2007-05-31 2015-02-05 Sunovion Pharmaceuticals Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
WO2009151498A2 (en) * 2008-03-28 2009-12-17 Forest Laboratories Holdings Limited Memantine formulations
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
CA2755118A1 (en) * 2009-03-10 2010-09-16 Santen Pharmaceutical Co., Ltd. Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
PT3137658T (pt) 2014-04-30 2022-05-05 Univ Nat Taiwan Uso de compostos conhecidos como inibidores do d-aminoácido oxidase
EP3512840B1 (en) 2016-09-14 2024-03-06 Yufeng Jane Tseng Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors
MX393950B (es) 2017-06-12 2025-03-24 Glytech Llc Composicion y metodo para el tratamiento de la depresion y psicosis en humanos
CN112707874A (zh) * 2020-12-29 2021-04-27 广东中科药物研究有限公司 一种抗病毒化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010971A (en) * 1960-08-04 1961-11-28 Smith Kline French Lab Cyclopropylamine derivatives and processes for their preparation
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
KR0178469B1 (ko) * 1990-07-16 1999-03-20 메이나드 알. 존슨 흥분성 아미노산 길항제
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity

Also Published As

Publication number Publication date
PL176451B1 (pl) 1999-05-31
JPH0649027A (ja) 1994-02-22
DK43193A (da) 1993-10-17
CZ254394A3 (en) 1995-07-12
ATA75293A (de) 1997-11-15
SK124194A3 (en) 1995-05-10
DK43193D0 (da) 1993-04-15
ZA932642B (en) 1994-01-10
RO113242B1 (ro) 1998-05-29
FI106198B (fi) 2000-12-15
GB2266091A (en) 1993-10-20
EP0568136A1 (en) 1993-11-03
HU211826A9 (en) 1995-12-28
FR2690919A1 (fr) 1993-11-12
IL105412A (en) 1998-02-22
KR100264114B1 (ko) 2000-11-01
JPH07505407A (ja) 1995-06-15
IL105412A0 (en) 1993-08-18
SE504336C2 (sv) 1997-01-13
GEP19991704B (en) 1999-08-05
SE9301241D0 (sv) 1993-04-15
SK281941B6 (sk) 2001-09-11
US5510367A (en) 1996-04-23
CZ285799B6 (cs) 1999-11-17
MX9302195A (es) 1994-03-31
HK95797A (en) 1997-08-08
AU666927B2 (en) 1996-02-29
OA10103A (en) 1996-12-18
FI944800L (fi) 1994-10-12
IS3994A (is) 1993-10-17
FR2690919B1 (fr) 1995-05-05
SE9301241L (sv) 1993-10-17
ITRM930236A0 (it) 1993-04-15
DK169890B1 (da) 1995-03-27
AP9300524A0 (en) 1993-04-30
TW224457B (https=) 1994-06-01
MY112232A (en) 2001-05-31
RU94045915A (ru) 1996-09-10
US5374648A (en) 1994-12-20
AU3692393A (en) 1993-10-21
BE1006343A5 (fr) 1994-07-26
NO943913D0 (no) 1994-10-14
FI944800A0 (fi) 1994-10-12
CA2094073A1 (en) 1993-10-17
BG99111A (bg) 1995-05-31
AT403917B (de) 1998-06-25
NO943913L (no) 1994-12-14
GB9307808D0 (en) 1993-06-02
ES2105924A1 (es) 1997-10-16
ITRM930236A1 (it) 1994-10-15
NZ247413A (en) 1995-12-21
HUT70526A (en) 1995-10-30
CN1085212A (zh) 1994-04-13
LU88248A1 (fr) 1994-03-01
HU217964B (hu) 2000-05-28
BR1100323A (pt) 2000-06-27
CY2038B1 (en) 1998-04-30
CA2094076A1 (en) 1993-10-17
CH685630A5 (fr) 1995-08-31
ES2105924B1 (es) 1998-07-01
US5374649A (en) 1994-12-20
US5373018A (en) 1994-12-13
IT1265325B1 (it) 1996-10-31
NO301879B1 (no) 1997-12-22
WO1993021153A1 (en) 1993-10-28
RU2129544C1 (ru) 1999-04-27
CN1042331C (zh) 1999-03-03
AP480A (en) 1996-03-22
GR1001619B (el) 1994-07-29
BG62136B1 (bg) 1999-03-31
CA2094075A1 (en) 1993-10-17
GB2266091B (en) 1995-08-09
HU9402975D0 (en) 1995-02-28

Similar Documents

Publication Publication Date Title
HU9402443D0 (en) Heterocyclic compounds
GB9208492D0 (en) Heterocyclic compounds
GB9304500D0 (en) Heterocyclic compounds
IL106971A0 (en) Heterocyclic compounds
IL108125A0 (en) Heterocyclic compounds
GB9215361D0 (en) Heterocyclic compounds
HU9300217D0 (en) Heterocyclic compounds
GB9219632D0 (en) Heterocyclic compounds
GB9317761D0 (en) Heterocyclic compounds
GB9319243D0 (en) Heterocyclic compounds
GB9223371D0 (en) Heterocyclic compounds
GB9207517D0 (en) Heterocyclic compounds
GB9218240D0 (en) Heterocyclic compounds
GB9208380D0 (en) Heterocyclic compounds
GB9203496D0 (en) Heterocyclic compounds
GB9208496D0 (en) Heterocyclic compounds
GB9203480D0 (en) Heterocyclic compounds
ZA932697B (en) Heterocyclic compounds
GB9217362D0 (en) Heterocyclic compounds
GB9208505D0 (en) Heterocyclic compounds
GB9203607D0 (en) Heterocyclic compounds
GB9212924D0 (en) Heterocyclic compounds
GB9219733D0 (en) Heterocyclic compounds
GB9215360D0 (en) Heterocyclic compounds
GB9216779D0 (en) Heterocyclic compounds